Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Department of Dermatology, University of California, San Francisco, California.
J Am Acad Dermatol. 2024 May;90(5):885-908. doi: 10.1016/j.jaad.2023.02.072. Epub 2023 Jul 27.
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction (SCAR) characterized by an exanthem, fever, and hematologic and visceral organ involvement. Anticonvulsants, antibiotics, and allopurinol are the most common triggers. The pathogenesis involves a complex interplay between drugs, viruses, and the immune system primarily mediated by T-cells. DiHS/DRESS typically presents with a morbilliform eruption 2-6 weeks after drug exposure, and is associated with significant morbidity, mortality, and risk of relapse. Long-term sequelae primarily relate to organ dysfunction and autoimmune diseases. Part I of this continuing medical education activity on DiHS/DRESS provides an update on epidemiology, novel insights into pathogenesis, and a description of clinicopathological features and prognosis.
药物诱导的超敏反应综合征(DiHS),又称药物反应伴嗜酸性粒细胞增多和全身症状(DRESS),是一种严重的皮肤不良反应(SCAR),其特征为出疹、发热以及血液和内脏器官受累。抗惊厥药、抗生素和别嘌醇是最常见的触发因素。发病机制涉及药物、病毒和免疫系统之间的复杂相互作用,主要由 T 细胞介导。DiHS/DRESS 通常在药物暴露后 2-6 周出现麻疹样皮疹,且与较高的发病率、死亡率和复发风险相关。长期后遗症主要与器官功能障碍和自身免疫性疾病有关。本次关于 DiHS/DRESS 的继续教育活动第一部分介绍了其流行病学、发病机制方面的新见解,以及临床表现和预后的特征。